Repurposing astemizole to kill multidrug-resistant bacteria isolated in general surgery
- 8 February 2025
- journal article
- Published by Elsevier in Microbial Pathogenesis
- Vol. 200, 107369
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Anti-fibrotic effects of statin drugs: A review of evidence and mechanismsBiochemical Pharmacology, 2023
- Target- and prodrug-based design for fungal diseases and cancer-associated fungal infectionsAdvanced Drug Delivery Reviews, 2023
- Surgical site infections caused by multi-drug resistant organisms: a case–control study in general surgeryUpdates in Surgery, 2022
- Antimicrobial Resistance in Bacteria: Mechanisms, Evolution, and PersistenceJournal of Molecular Evolution, 2019
- Constructing and deconstructing the bacterial cell wallProtein Science, 2019
- Drug repurposing: a promising tool to accelerate the drug discovery processDrug Discovery Today, 2019
- In Vivo Determination of Mitochondrial Function Using Luciferase‐ExpressingCaenorhabditis elegans: Contribution of Oxidative Phosphorylation, Glycolysis, and Fatty Acid Oxidation to Toxicant‐Induced DysfunctionCurrent Protocols in Toxicology, 2016
- Infections Caused by Resistant Gram‐Negative Bacteria: Epidemiology and ManagementPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2015
- Genetically encoded reactive oxygen species (ROS) and redox indicatorsBiotechnology Journal, 2014
- Effect of Energy Metabolism on Protein Motility in the Bacterial Outer MembraneBiophysical Journal, 2009